Aria Pharmaceuticals
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin.
3
Funding Rounds
$14.3m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** A. Ra*** | - | - | linkedin twitter |
| An**** M. Ra*** | - | - | linkedin twitter |
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** A. Ra*** | - | - | linkedin twitter |
| Sh***** Li | - | - | - |
| Jo*** Co*** (i******** | - | - | linkedin twitter |
| Ho**** Ro*** | - | - | - |
Funding series
Funding Series Analysis
The company Aria Pharmaceuticals has raised a total of $4.3m in funding over 3 rounds.
Key Insights:
- twoXAR Seed round, November 2015: $3.4m
- twoXAR Seed round, May 2015: $900k
- TwoXAR Inc funding round, March 2018: $10m
twoXAR Seed round, November 2015
$3.4m
twoXAR Seed round, May 2015
$900k
TwoXAR Inc funding round, March 2018
$10m
Industries
Aria Pharmaceuticals is active in the following industries:
- Autoimmune disease
- Biomedical engineering
- Artificial Intelligence (AI)
- Analytics
- Drug discovery
- Big data
- Technology
- Biology
- Biotechnology
- Engineering
- Synthetic chemistry